vs

Side-by-side financial comparison of Oncology Institute, Inc. (TOI) and Townsquare Media, Inc. (TSQ). Click either name above to swap in a different company.

Oncology Institute, Inc. is the larger business by last-quarter revenue ($142.0M vs $106.5M, roughly 1.3× Townsquare Media, Inc.). Townsquare Media, Inc. runs the higher net margin — -4.9% vs -5.3%, a 0.4% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs -9.6%). Townsquare Media, Inc. produced more free cash flow last quarter ($9.2M vs $2.2M). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs 3.4%).

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

Townsquare Media, Inc. is an American radio network and media company based in Purchase, New York. The company started in radio and expanded into digital media toward the end of the 2000s, starting with the acquisition of the MOG Music Network. As of June 2024, Townsquare was the third-largest AM–FM operator in the country, owning 349 radio stations in 74 markets.

TOI vs TSQ — Head-to-Head

Bigger by revenue
TOI
TOI
1.3× larger
TOI
$142.0M
$106.5M
TSQ
Growing faster (revenue YoY)
TOI
TOI
+51.2% gap
TOI
41.6%
-9.6%
TSQ
Higher net margin
TSQ
TSQ
0.4% more per $
TSQ
-4.9%
-5.3%
TOI
More free cash flow
TSQ
TSQ
$7.0M more FCF
TSQ
$9.2M
$2.2M
TOI
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
3.4%
TSQ

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
TOI
TOI
TSQ
TSQ
Revenue
$142.0M
$106.5M
Net Profit
$-7.5M
$-5.2M
Gross Margin
24.1%
Operating Margin
-4.9%
9.5%
Net Margin
-5.3%
-4.9%
Revenue YoY
41.6%
-9.6%
Net Profit YoY
43.0%
-121.2%
EPS (diluted)
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TOI
TOI
TSQ
TSQ
Q4 25
$142.0M
$106.5M
Q3 25
$136.6M
$106.8M
Q2 25
$119.8M
$115.4M
Q1 25
$104.4M
$98.7M
Q4 24
$100.3M
$117.8M
Q3 24
$99.9M
$115.3M
Q2 24
$98.6M
$118.2M
Q1 24
$94.7M
$99.6M
Net Profit
TOI
TOI
TSQ
TSQ
Q4 25
$-7.5M
$-5.2M
Q3 25
$-16.5M
$-5.9M
Q2 25
$-17.0M
$1.6M
Q1 25
$-19.6M
$-2.0M
Q4 24
$-13.2M
$24.6M
Q3 24
$-16.1M
$10.8M
Q2 24
$-15.5M
$-49.2M
Q1 24
$-19.9M
$1.1M
Gross Margin
TOI
TOI
TSQ
TSQ
Q4 25
24.1%
Q3 25
26.2%
Q2 25
28.3%
Q1 25
23.2%
Q4 24
31.6%
Q3 24
27.3%
Q2 24
27.7%
Q1 24
22.8%
Operating Margin
TOI
TOI
TSQ
TSQ
Q4 25
-4.9%
9.5%
Q3 25
-5.9%
5.6%
Q2 25
-9.4%
18.2%
Q1 25
-9.5%
7.2%
Q4 24
-11.9%
18.1%
Q3 24
-13.9%
13.1%
Q2 24
-16.6%
-18.1%
Q1 24
-19.0%
6.7%
Net Margin
TOI
TOI
TSQ
TSQ
Q4 25
-5.3%
-4.9%
Q3 25
-12.1%
-5.5%
Q2 25
-14.2%
1.4%
Q1 25
-18.8%
-2.0%
Q4 24
-13.1%
20.8%
Q3 24
-16.1%
9.4%
Q2 24
-15.7%
-41.7%
Q1 24
-21.0%
1.1%
EPS (diluted)
TOI
TOI
TSQ
TSQ
Q4 25
$-0.04
Q3 25
$-0.14
$-0.36
Q2 25
$-0.15
$0.09
Q1 25
$-0.21
$-0.12
Q4 24
$-0.14
$1.76
Q3 24
$-0.18
$0.63
Q2 24
$-0.17
$-3.26
Q1 24
$-0.22
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TOI
TOI
TSQ
TSQ
Cash + ST InvestmentsLiquidity on hand
$4.8M
Total DebtLower is stronger
$433.0M
Stockholders' EquityBook value
$-15.7M
$-41.0M
Total Assets
$164.7M
$528.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TOI
TOI
TSQ
TSQ
Q4 25
$4.8M
Q3 25
$3.2M
Q2 25
$3.2M
Q1 25
$5.5M
Q4 24
$33.0M
Q3 24
$21.8M
Q2 24
$9.9M
$28.5M
Q1 24
$29.8M
$56.6M
Total Debt
TOI
TOI
TSQ
TSQ
Q4 25
$433.0M
Q3 25
$437.6M
Q2 25
$439.7M
Q1 25
$448.4M
Q4 24
$465.8M
Q3 24
$476.7M
Q2 24
$487.1M
Q1 24
$500.1M
Stockholders' Equity
TOI
TOI
TSQ
TSQ
Q4 25
$-15.7M
$-41.0M
Q3 25
$-12.3M
$-34.0M
Q2 25
$-9.0M
$-27.1M
Q1 25
$5.1M
$-26.8M
Q4 24
$3.6M
$-28.4M
Q3 24
$15.5M
$-52.5M
Q2 24
$29.2M
$-64.1M
Q1 24
$41.3M
$1.8M
Total Assets
TOI
TOI
TSQ
TSQ
Q4 25
$164.7M
$528.6M
Q3 25
$163.6M
$539.2M
Q2 25
$159.8M
$545.7M
Q1 25
$164.0M
$544.5M
Q4 24
$172.7M
$580.4M
Q3 24
$179.2M
$565.4M
Q2 24
$179.6M
$579.6M
Q1 24
$204.5M
$636.7M
Debt / Equity
TOI
TOI
TSQ
TSQ
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
271.80×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TOI
TOI
TSQ
TSQ
Operating Cash FlowLast quarter
$3.2M
$12.6M
Free Cash FlowOCF − Capex
$2.2M
$9.2M
FCF MarginFCF / Revenue
1.5%
8.6%
Capex IntensityCapex / Revenue
0.7%
3.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-27.8M
$15.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TOI
TOI
TSQ
TSQ
Q4 25
$3.2M
$12.6M
Q3 25
$-12.6M
$7.9M
Q2 25
$-10.2M
$10.2M
Q1 25
$-5.0M
$-66.0K
Q4 24
$4.2M
$28.2M
Q3 24
$819.0K
$9.9M
Q2 24
$-15.7M
$9.0M
Q1 24
$-15.9M
$1.7M
Free Cash Flow
TOI
TOI
TSQ
TSQ
Q4 25
$2.2M
$9.2M
Q3 25
$-13.2M
$4.3M
Q2 25
$-11.4M
$6.4M
Q1 25
$-5.3M
$-4.5M
Q4 24
$2.4M
$24.5M
Q3 24
$417.0K
$4.8M
Q2 24
$-17.5M
$4.8M
Q1 24
$-16.5M
$-2.8M
FCF Margin
TOI
TOI
TSQ
TSQ
Q4 25
1.5%
8.6%
Q3 25
-9.7%
4.1%
Q2 25
-9.5%
5.5%
Q1 25
-5.1%
-4.6%
Q4 24
2.4%
20.8%
Q3 24
0.4%
4.1%
Q2 24
-17.7%
4.0%
Q1 24
-17.4%
-2.8%
Capex Intensity
TOI
TOI
TSQ
TSQ
Q4 25
0.7%
3.2%
Q3 25
0.4%
3.3%
Q2 25
1.0%
3.3%
Q1 25
0.3%
4.5%
Q4 24
1.8%
3.1%
Q3 24
0.4%
4.4%
Q2 24
1.9%
3.6%
Q1 24
0.6%
4.4%
Cash Conversion
TOI
TOI
TSQ
TSQ
Q4 25
Q3 25
Q2 25
6.51×
Q1 25
Q4 24
1.15×
Q3 24
0.91×
Q2 24
Q1 24
1.47×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

TSQ
TSQ

Broadcast Advertising Segment$46.4M44%
Digital Advertising Segment$41.7M39%
Subscription Digital Marketing Solutions Segment$18.4M17%

Related Comparisons